A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
Stanford Storybank, organized by Stanford Health Care, collects 40-minute audio stories from patients and members of the Stanford Medicine community.
After Aditi Polamreddy's brain tumor was removed, she needed physical and occupational therapy to keep her brain from forgetting one side of her body.
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
Six groups of researchers collaborated to study the effect of advances in breast cancer screening and treatment on mortality rates.
A conversation with Becky Hall and the short film she made about shaving her head before chemotherapy.
Loss of taste sensation occurs in about 85 percent of cancer patients receiving chemotherapy. A new Stanford study explored the problem.
Three-time cancer survivor Fred Reiss uses comedy to share his experience with the disease.
Immune cells spot cancer cells by locating proteins called antigens. Now, researchers have developed a new tool that will help them identify those antigens.
As a parent, some stories are more difficult to write than others. My recent Stanford Medicine magazine article about kids with leukemia is an example. …
In a growing movement toward targeted, less-toxic cancer therapies, physicians are growing increasingly less likely to recommend chemotherapy treatment in some early-stage breast cancer patients, …